Jue Pu
Directeur/Membre du Conseil chez LEPU BIOPHARMA CO., LTD.
Fortune : 59 M $ au 31/05/2024
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Eric Rowinsky | M | 67 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 9 ans |
Ambaw Bellete | M | 54 | 1 ans | |
De Min Zhou | M | 58 | 4 ans | |
Ziye Sui | M | - | 4 ans | |
Saeed Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 14 ans |
Yun Yi Li | F | 44 | 4 ans | |
Hai Feng Yang | M | 47 | 4 ans | |
Victor Tong | M | 41 | 1 ans | |
Zhong Jie Pu | M | 61 | 6 ans | |
Feng Mao Hua | M | 56 | 3 ans | |
Brian Liu | M | 36 | 2 ans | |
David Mangelsdorf | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
peter vlasselaer | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 ans |
Maggie Geman Li | F | 58 | 4 ans | |
Hu Li | M | 59 | 4 ans | |
Lei Fang | M | 41 | 4 ans | |
Tess Hau | F | - |
Stanford University
| 12 ans |
Min MIn Qin | M | 66 | 4 ans | |
Vijay Kasturi | M | 57 | 1 ans | |
Raymond Camahort | M | 45 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 ans |
Hongbing Yang | M | 55 | 4 ans | |
Jiwei Wang | M | 37 | 4 ans | |
Nancy T. Chang | M | 74 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Ming Yang | M | 58 | 4 ans | |
Dieter Weinand | M | 63 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 3 ans |
Siu Kuen Lai | F | 48 | 3 ans | |
Nilesh Kumar | M | 47 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Yang Xu | M | 57 | 4 ans | |
Usman Azam | M | 55 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 1 ans |
Peter van Vlasselaer | M | 64 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 6 ans |
Antoine Papiernik | M | 56 |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | - |
Swapnil Bhargava | M | - | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Masoud Tavazoie | M | - |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | 13 ans |
Steven Kozhimala | M | - |
The Wharton School of the University of Pennsylvania
| 10 ans |
Pranav Gupta | M | - |
The Wharton School of the University of Pennsylvania
| 13 ans |
Peter Moran | M | - |
Stanford University
| 4 ans |
Emily Janvey | M | - |
The Wharton School of the University of Pennsylvania
| 5 ans |
Yi Peng Li | M | 47 | - | |
Sapna Tejwani Jethwa | F | - |
The Wharton School of the University of Pennsylvania
| 11 ans |
Raakhe Kapoor Tandon | F | - |
The Wharton School of the University of Pennsylvania
| 5 ans |
Eli Simon | M | - |
The Wharton School of the University of Pennsylvania
| 5 ans |
Greg Kress | M | - |
Stanford University
| 5 ans |
Haomiao Huang | M | - |
Stanford University
| 7 ans |
Neel Murthy | M | - |
Stanford University
| 6 ans |
Vandit D. Shah | M | - |
The Wharton School of the University of Pennsylvania
| 3 ans |
Steven Finn | M | 38 |
The Wharton School of the University of Pennsylvania
| 4 ans |
Kristen Wong | F | - |
Stanford University
| 4 ans |
Sydney Werber | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Chao Hong Hu | M | 58 | 4 ans | |
Xiaohan Zhu | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Edward Segal | M | - |
Stanford University
| 4 ans |
Eric Sun | M | - |
The Wharton School of the University of Pennsylvania
| 11 ans |
Christine Black | F | - |
The Wharton School of the University of Pennsylvania
| 10 ans |
Jing Lin | F | - |
The Wharton School of the University of Pennsylvania
| 8 ans |
Jennifer Rowland | F | - |
The Wharton School of the University of Pennsylvania
| 5 ans |
Jordan Moelis | M | - |
The Wharton School of the University of Pennsylvania
| 5 ans |
Sahil Bloom | M | - |
Stanford University
| 4 ans |
Rama Sekhar | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
David Bard | M | - |
The Wharton School of the University of Pennsylvania
| 12 ans |
Stewart Lynn | M | - |
Stanford University
| 5 ans |
Rashad Rahman | M | - |
The Wharton School of the University of Pennsylvania
| 15 ans |
Justin Green | M | - |
The Wharton School of the University of Pennsylvania
| 11 ans |
Chase Beeler | M | - |
Stanford University
| 5 ans |
Samir Siddhanti | M | - |
Stanford University
| 5 ans |
Samir Malik | M | - |
The Wharton School of the University of Pennsylvania
| 7 ans |
Shirin Bohra | F | - |
The Wharton School of the University of Pennsylvania
| 12 ans |
Rohit Nagpal | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Talal Arij Khan | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Rachel Presser | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Nagendra Jayanty | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Patrick Sullivan | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Dan Harrison | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Peter Gajdos | M | 41 |
The Wharton School of the University of Pennsylvania
| 2 ans |
Lucia S. Kim | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Charles H. Tingue | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Joel Hwang | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
David Choi | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Eurie Kim | F | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Erin Shipley | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Amy Chang | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Gregory Dabrowski | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Xiang Qian Lin | M | 40 |
The Wharton School of the University of Pennsylvania
| 4 ans |
Ethan Chung | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Brian Laurence Hinkes | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Edward Chung | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Andrew Fohrer | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Liam Localio | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Brooks Powlen | M | - |
The Wharton School of the University of Pennsylvania
| 3 ans |
Amy X. Liu | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Jennifer Chen Lai | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Alan Tse | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Andrew Pon | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Kelly Zhou | F | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Jamie Anderson | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Bianca Stoica | F | 31 |
The Wharton School of the University of Pennsylvania
| 4 ans |
Mohaimin Altaf | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Christian Moore | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Andre Levy | M | - |
The Wharton School of the University of Pennsylvania
| 2 ans |
Joshua Salzman | M | - |
The Wharton School of the University of Pennsylvania
| 4 ans |
Thomas Colligan | M | 79 |
The Wharton School of the University of Pennsylvania
| 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 83 | 83,00% |
Chine | 17 | 17,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations